» Articles » PMID: 26583143

Calreticulin Binds to Fas Ligand and Inhibits Neuronal Cell Apoptosis Induced by Ischemia-Reperfusion Injury

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2015 Nov 20
PMID 26583143
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Calreticulin (CRT) can bind to Fas ligand (FasL) and inhibit Fas/FasL-mediated apoptosis of Jurkat T cells. However, its effect on neuronal cell apoptosis has not been investigated.

Purpose: We aimed to evaluate the neuroprotective effect of CRT following ischemia-reperfusion injury (IRI).

Methods: Mice underwent middle cerebral artery occlusion (MCAO) and SH-SY5Y cells subjected to oxygen glucose deprivation (OGD) were used as models for IRI. The CRT protein level was detected by Western blotting, and mRNA expression of CRT, caspase-3, and caspase-8 was measured by real-time PCR. Immunofluorescence was used to assess the localization of CRT and FasL. The interaction of CRT with FasL was verified by coimmunoprecipitation. SH-SY5Y cell viability was determined by MTT assay, and cell apoptosis was assessed by flow cytometry. The measurement of caspase-8 and caspase-3 activity was carried out using caspase activity assay kits.

Results: After IRI, CRT was upregulated on the neuron surface and bound to FasL, leading to increased viability of OGD-exposed SH-SY5Y cells and decreased activity of caspase-8 and caspase-3.

Conclusions: This study for the first time revealed that increased CRT inhibited Fas/FasL-mediated neuronal cell apoptosis during the early stage of ischemic stroke, suggesting it to be a potential protector activated soon after IRI.

Citing Articles

Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles.

Lee J, Geum D, Park D, Kim J Pharmaceutics. 2025; 16(12.

PMID: 39771472 PMC: 11678501. DOI: 10.3390/pharmaceutics16121492.


Systemic Treatment with Fas-Blocking Peptide Attenuates Apoptosis in Brain Ischemia.

Chung S, Yi Y, Ullah I, Chung K, Park S, Lim J Int J Mol Sci. 2024; 25(1).

PMID: 38203830 PMC: 10780202. DOI: 10.3390/ijms25010661.


Ethyl pyruvate attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells: Role of GAS6/Axl signaling.

Chen Y, Chen J, Zhao L, Zhang X, Wu X, Wang X Heliyon. 2023; 9(12):e22787.

PMID: 38090008 PMC: 10711176. DOI: 10.1016/j.heliyon.2023.e22787.


Neuronal Responses to Ischemia: Scoping Review of Insights from Human-Derived In Vitro Models.

Voogd E, Frega M, Hofmeijer J Cell Mol Neurobiol. 2023; 43(7):3137-3160.

PMID: 37380886 PMC: 10477161. DOI: 10.1007/s10571-023-01368-y.


The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment.

Sun H, Wu M, Wang M, Zhang X, Zhu J Front Neurosci. 2022; 16:1032607.

PMID: 36458041 PMC: 9705995. DOI: 10.3389/fnins.2022.1032607.


References
1.
Shin D, Lee E, Kim H, Kim S, Cho S, Chang K . Fas ligand mRNA expression in the mouse central nervous system. J Neuroimmunol. 2002; 123(1-2):50-7. DOI: 10.1016/s0165-5728(01)00478-7. View

2.
Zhang M, Li Q, Chen L, Li J, Zhang X, Chen X . PSD-93 deletion inhibits Fyn-mediated phosphorylation of NR2B and protects against focal cerebral ischemia. Neurobiol Dis. 2014; 68:104-11. DOI: 10.1016/j.nbd.2014.04.010. View

3.
Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J . CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci. 1999; 19(10):3809-17. PMC: 6782733. View

4.
Duus K, Pagh R, Holmskov U, Hojrup P, Skov S, Houen G . Interaction of calreticulin with CD40 ligand, TRAIL and Fas ligand. Scand J Immunol. 2007; 66(5):501-7. DOI: 10.1111/j.1365-3083.2007.01999.x. View

5.
Rosell A, Cuadrado E, Alvarez-Sabin J, Hernandez-Guillamon M, Delgado P, Penalba A . Caspase-3 is related to infarct growth after human ischemic stroke. Neurosci Lett. 2007; 430(1):1-6. DOI: 10.1016/j.neulet.2007.05.006. View